Markets
EEM

ETF Preview: ETFs, Futures in Positive Territory Following Strong Jobs Report

Active broad-market exchange-traded funds ahead of Friday's regular session:

VelocityShares 3x Long Natural Gas ETN ( UGAZ ): +4.7%

iShares MSCI Emerging Index Fund ( EEM ): +1.1%

SPDR S&P 500 ( SPY ): +0.3%

SPDR Select Sector Fund - Financial ( XLF ): +0.5%

United States Natural Gas Fund LP ( UNG ): +1.5%

Broad Market Indicators

Broad-market exchange-traded funds, including SPY, IWM and IVV were higher. Actively traded PowerShares QQQ (QQQ) was up 0.6%.

US stock futures were higher ahead of the open, buoyed by the report that the U.S. economy created 228,000 jobs in November, versus expectations for a 190,000 increase in nonfarm jobs. The unemployment rate remained the same at 4.1%. Wages rose 0.2% to an average of $26.55 an hour, while worker pay increased 2.5% from the same month last year, and up from 2.3% in the prior month. The average workweek rose 0.1 hour to 34.5 hours.

Investors are now looking ahead to the December reading for consumer sentiment, as well as the October reading for wholesale inventories, both coming out at 10 am ET.

Power Play: Health Care

Health care funds Health Care SPDR (XLV), Vanguard Health Care ETF (VHT) and iShares Dow Jones US Healthcare (IYH), were quiet. Biotechnology fund iShares NASDAQ Biotechnology Index (IBB) was up 0.4%.

TrovaGene (TROV) rose more than 15% after the company said late Thursday that pre-clinical data demonstrates the sensitivity of triple-negative breast cancer cell lines to its anti-cancer drug, dubbed PCM-075. The company said the pre-clinical analysis of 40 cancer cell lines demonstrated that triple-negative breast cancer cell lines are 20-fold more sensitive to PCM-075 than estrogen-receptor positive breast cancer cells lines, and that PCM-075 shows promise in combination with other drugs, such as abiraterone acetate. The drug company said the outlook for patients with triple-negative breast cancer is poor, but PCM-075 with abiraterone acetate or other treatments may provide a new therapeutic option.

Winners and Losers

Financial

Select Financial Sector SPDRs ( XLF ) was up 0.5%. Direxion Daily Financial Bull 3X shares (FAS) was up 1.2% while its bearish counterpart, FAZ was down 1.1% in pre-market trade.

Royal Bank of Scotland's (RBS) chances of reaching a deal this year with the US Department of Justice related to its sales of mortgage-backed securities are "diminishing," according to a Bloomberg TV interview with RBS CEO Ross McEwan. "There are diminishing chances" the bank will settle with the U.S. Department of Justice in 2017, "but this is something that we do want to resolve," McEwan said. "We are in a very strong capital position," McEwan said. "I think there is a lot of distraction in the Department of Justice with other issues in the United States. I'm not too sure where we sit in the priority list." A deal would eliminate the biggest remaining obstacle to RBS resuming dividends. McEwan said that when RBS does restore dividends, it will start "small" before considering special payouts.

Technology

Tech funds Technology Select Sector SPDR ETF (XLK), iShares Dow Jones US Technology ETF (IYW), iShares S&P North American Technology ETF (IGM) and iShares S&P North American Technology-Software Index (IGV) were flat.

Among semiconductor ETFs, SPDR S&P Semiconductor (XSD) and Semiconductor Sector Index Fund (SOXX) were both inactive.

Cloudera (CLDR) rose 7.8% after it posted late Thursday better-than-expected Q3 results while guiding to smaller quarterly and yearly losses than consensus. Non-GAAP net loss was $0.17 per share in Q3, a smaller loss than analysts' estimate of $0.24 loss a share in a Capital IQ poll, and narrowing from net loss of $0.34 a share a year earlier. Revenue jumped 41% to $94.6 million from $67.26 million a year ago, also exceeding the $91.31 million estimate. For Q4, it expects revenue of $97 million to $99 million and non-GAAP net loss per share in the range of $0.24 to $0.22 per share, compared with market consensus of net loss of $0.26 per share on revenue of $97.3 million. For fiscal 2018, revenue is forecast at $361 million to $363 million and non-GAAP net loss per share in the range of $0.84 to $0.82 per share, against expectations of net loss of $0.93 per share on revenue of $358.67 million.

Energy

Dow Jones US Energy Fund (IYE) was inactive and Energy Select Sector SPDR (XLE) was up 1.1%.

Transocean (RIG) has reported in an SEC filing that its subsidiary, Global Marine Inc., has been sued by Wilmington Trust Company, seeking a declaratory judgment that Global Marine is in default under the indenture governing its $300 million of outstanding 7.00% Notes due June 2028. Transocean said it disagrees with the assertions in the lawsuit, and believes Global Marine is in compliance with the indenture. It said the notes are neither guaranteed by, nor recourse to, the company or other subsidiaries of the company. RIG shares were up 1.7%.

Commodities

Crude was up 1.9%. United States Oil Fund (USO) was up 1.9%. Natural gas was up 1.7% while United States Natural Gas Fund ( UNG ) was up 1.3%

Gold was down 0.3%. SPDR Gold Trust (GLD) was down 0.2%. Silver was up 0.2%, while iShares Silver Trust (SLV) was up 0.4%.

Consumer

Consumer Staples Select Sector SPDR (XLP), Vanguard Consumer Staples ETF (VDC) and iShares Dow Jones US Consumer Goods (IYK) were inactive.

Consumer Discretionary Select Sector SPDR (XLY) rose 0.3% and retail funds SPDR S&P Retail (XRT), PowerShares Dynamic Retail (PMR) and Market Vectors Retail ETF (RTH) were flat.

United Natural Foods (UNFI) was down 0.3% after it reported Q1 sales were $2.46 billion, up 7.9% from year ago levels and better than the analyst consensus of $2.39 billion on Capital IQ. Earnings were $0.60 per share, up from $0.58 per share in the same quarter last year and in line with the Street view. For FY 2018, the company expects sales in the range of $9.84 to $10 billion, up from previous guidance of $9.63 to $9.81 billion and ahead of expectations of $9.71 billion. EPS is seen at $2.72 to $2.80, up from its previous guidance of $2.67 to $2.77 per share and in line to above the Street consensus of $2.72 per share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EEM UGAZ SPY UNG XLF

Other Topics

ETFs